52 results
6-K
REPCF
Replicel Life Sciences Inc.
26 Oct 11
Current report (foreign)
12:00am
conditions that must be satisfied in connection with the payment of executive compensation.
The Board has recently appointed a Governance … was reviewed, recommended and approved by the Board. The Company expects that the newly formed Governance and Nominating Committee will oversee
6-K
REPCF
Replicel Life Sciences Inc.
17 May 12
Current report (foreign)
12:00am
Committee of the Company.
Member of the Governance and Nominating Committee of the Company.
Does not include 1,000,000 shares held by Mr. Hall’s wife … determinations of the fair market value of the Shares underlying the options on the date of grant.
Compensation Governance
The Board has not adopted
6-K
REPCF
Replicel Life Sciences Inc.
23 May 13
Current report (foreign)
12:00am
of the Audit Committee of the Company.
Member of the Governance and Nominating Committee of the Company.
Does not include 1,000,000 shares held by Mr … of the fair market value of the Shares underlying the options on the date of grant.
Compensation Governance
The Board has not adopted any specific policies
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
22 Jan 19
Current report (foreign)
4:43pm
commercial executive having held a number of governance roles, with experience in the United Kingdom and New Zealand markets. As a Director and Consultant … and Corporate Governance Committee of the Company.
Does not include 100,000 Shares held by Mr. Hall’s wife over which Mr. Hall does not exercise control
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
Lowry(3)(4)(5)
Auckland, New Zealand
Director
Mr. Lowry is an experienced executive having held a number of governance roles, with experience … ) Member of the Nominating, Compensation and Corporate Governance Committee of the Company.
(5) Member of the Operations Committee of the Company.
(6
6-K
EX-99.1
728vlmuwfjf69pi8pbq1
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
st903h4 w9o
7 Jun 07
Current report (foreign)
12:00am
6-K
g9ask
24 Nov 10
Current report (foreign)
12:00am
6-K
bp7muxgwu5z4okqnq
21 Sep 06
Current report (foreign)
12:00am
6-K
EX-99.4
w0cvx18 k7n
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
0hnbe
15 Oct 09
Current report (foreign)
12:00am
6-K
EX-99.2
2urri0tm7 y6l
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
6-K
EX-99.1
0hahpiw2x9p oqczrg
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
20-F/A
2mhfr2g352ojxoq
12 Jan 18
Annual report (foreign) (amended)
12:00am